Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 2
1986 4
1987 3
1988 3
1989 5
1990 7
1991 1
1992 5
1993 3
1994 7
1995 4
1996 5
1997 5
1998 4
1999 9
2000 2
2001 6
2002 7
2003 4
2004 2
2005 6
2006 12
2007 8
2008 8
2009 8
2010 8
2011 7
2012 6
2013 13
2014 32
2015 17
2016 21
2017 19
2018 14
2019 12
2020 16
2021 19
2022 14
2023 10
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

300 results

Results by year

Filters applied: . Clear all
Page 1
Novel strategies exploiting interleukin-12 in cancer immunotherapy.
Cirella A, Luri-Rey C, Di Trani CA, Teijeira A, Olivera I, Bolaños E, Castañón E, Palencia B, Brocco D, Fernández-Sendin M, Aranda F, Berraondo P, Melero I. Cirella A, et al. Among authors: aranda f. Pharmacol Ther. 2022 Nov;239:108189. doi: 10.1016/j.pharmthera.2022.108189. Epub 2022 Apr 14. Pharmacol Ther. 2022. PMID: 35430292 Review.
Revisiting Intracavitary Immunotherapy of Cancer.
Aranda F, Eguren-Santamaria I, Bella Á, Berraondo P, Melero I. Aranda F, et al. Clin Cancer Res. 2022 May 13;28(10):1993-1995. doi: 10.1158/1078-0432.CCR-22-0201. Clin Cancer Res. 2022. PMID: 35247905
Trial Watch-Oncolytic viruses and cancer therapy.
Pol J, Buqué A, Aranda F, Bloy N, Cremer I, Eggermont A, Erbs P, Fucikova J, Galon J, Limacher JM, Preville X, Sautès-Fridman C, Spisek R, Zitvogel L, Kroemer G, Galluzzi L. Pol J, et al. Among authors: aranda f. Oncoimmunology. 2015 Dec 8;5(2):e1117740. doi: 10.1080/2162402X.2015.1117740. eCollection 2016 Feb. Oncoimmunology. 2015. PMID: 27057469 Free PMC article. Review.
CD5 as a Target for Immune-Based Therapies.
Consuegra-Fernández M, Aranda F, Simões I, Orta M, Sarukhan A, Lozano F. Consuegra-Fernández M, et al. Among authors: aranda f. Crit Rev Immunol. 2015;35(2):85-115. doi: 10.1615/critrevimmunol.2015013532. Crit Rev Immunol. 2015. PMID: 26351145 Review.
Trial Watch-Immunostimulation with cytokines in cancer therapy.
Vacchelli E, Aranda F, Bloy N, Buqué A, Cremer I, Eggermont A, Fridman WH, Fucikova J, Galon J, Spisek R, Zitvogel L, Kroemer G, Galluzzi L. Vacchelli E, et al. Among authors: aranda f. Oncoimmunology. 2015 Dec 8;5(2):e1115942. doi: 10.1080/2162402X.2015.1115942. eCollection 2016 Feb. Oncoimmunology. 2015. PMID: 27057468 Free PMC article. Review.
Overcoming the limitations of cytokines to improve cancer therapy.
Di Trani CA, Cirella A, Arrizabalaga L, Fernandez-Sendin M, Bella A, Aranda F, Melero I, Berraondo P. Di Trani CA, et al. Among authors: aranda f. Int Rev Cell Mol Biol. 2022;369:107-141. doi: 10.1016/bs.ircmb.2022.05.002. Epub 2022 May 30. Int Rev Cell Mol Biol. 2022. PMID: 35777862 Review.
Classification of current anticancer immunotherapies.
Galluzzi L, Vacchelli E, Bravo-San Pedro JM, Buqué A, Senovilla L, Baracco EE, Bloy N, Castoldi F, Abastado JP, Agostinis P, Apte RN, Aranda F, Ayyoub M, Beckhove P, Blay JY, Bracci L, Caignard A, Castelli C, Cavallo F, Celis E, Cerundolo V, Clayton A, Colombo MP, Coussens L, Dhodapkar MV, Eggermont AM, Fearon DT, Fridman WH, Fučíková J, Gabrilovich DI, Galon J, Garg A, Ghiringhelli F, Giaccone G, Gilboa E, Gnjatic S, Hoos A, Hosmalin A, Jäger D, Kalinski P, Kärre K, Kepp O, Kiessling R, Kirkwood JM, Klein E, Knuth A, Lewis CE, Liblau R, Lotze MT, Lugli E, Mach JP, Mattei F, Mavilio D, Melero I, Melief CJ, Mittendorf EA, Moretta L, Odunsi A, Okada H, Palucka AK, Peter ME, Pienta KJ, Porgador A, Prendergast GC, Rabinovich GA, Restifo NP, Rizvi N, Sautès-Fridman C, Schreiber H, Seliger B, Shiku H, Silva-Santos B, Smyth MJ, Speiser DE, Spisek R, Srivastava PK, Talmadge JE, Tartour E, Van Der Burg SH, Van Den Eynde BJ, Vile R, Wagner H, Weber JS, Whiteside TL, Wolchok JD, Zitvogel L, Zou W, Kroemer G. Galluzzi L, et al. Among authors: aranda f. Oncotarget. 2014 Dec 30;5(24):12472-508. doi: 10.18632/oncotarget.2998. Oncotarget. 2014. PMID: 25537519 Free PMC article. Review.
Trial watch: Immune checkpoint blockers for cancer therapy.
Vanpouille-Box C, Lhuillier C, Bezu L, Aranda F, Yamazaki T, Kepp O, Fucikova J, Spisek R, Demaria S, Formenti SC, Zitvogel L, Kroemer G, Galluzzi L. Vanpouille-Box C, et al. Among authors: aranda f. Oncoimmunology. 2017 Aug 31;6(11):e1373237. doi: 10.1080/2162402X.2017.1373237. eCollection 2017. Oncoimmunology. 2017. PMID: 29147629 Free PMC article. Review.
A focus on the roles of histones in health and diseases.
Moiana M, Aranda F, de Larrañaga G. Moiana M, et al. Among authors: aranda f. Clin Biochem. 2021 Aug;94:12-19. doi: 10.1016/j.clinbiochem.2021.04.019. Epub 2021 Apr 23. Clin Biochem. 2021. PMID: 33895124 Review.
Trial watch: Dendritic cell-based anticancer therapy.
Bloy N, Pol J, Aranda F, Eggermont A, Cremer I, Fridman WH, Fučíková J, Galon J, Tartour E, Spisek R, Dhodapkar MV, Zitvogel L, Kroemer G, Galluzzi L. Bloy N, et al. Among authors: aranda f. Oncoimmunology. 2014 Dec 21;3(11):e963424. doi: 10.4161/21624011.2014.963424. eCollection 2014 Nov. Oncoimmunology. 2014. PMID: 25941593 Free PMC article. Review.
300 results